1-2 of 2
Shuhei Kida, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Elevated Serum Soluble Interleukin-2 Receptor Level Is a Useful Prognostic Factor for Disease-Specific Overall Survival in Patients with Newly Diagnosed Follicular Lymphoma before Initiation of Treatment

Kenji Nozaki, MD, Hiroyuki Sugahara, MD PhD, Shuji Ueda, MD PhD, Jun Ishikawa, MD PhD, Shigeo Fuji, MD PhD, Hiroaki Masaie, MD PhD, Yuma Tada, MD, Makiko Suga, MD, Kazuhito Tsutsumi, MD, Kumi Shibata, MD, Shuhei Kida, MD, Takahiro Karasuno, MD PhD, Hiroshi Sata, MD PhD, Masato Yasumi, MD PhD, Masato Iida, MD PhD, Hideki Mitsui, MD PhD, Tsuyoshi Kamae, MD PhD, Norimitsu Saito, MD PhD, Hiraku Murakami, MD, Yasuhiro Moriyama, MD PhD, Manabu Kawakami, MD PhD, Ruri Kato, MD PhD, Yoshiki Nakae, MD PhD, Toru Kida, MD, Satoru Kosugi, MD PhD, Hirohiko Shibayama, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3985.
https://doi.org/10.1182/blood-2019-126399
Published: 2019
Journal Articles

Efficacy of Yttrium-90 Iburitumomab Tiuxetan for Early Relapsed/Refractory Indolent B-Cell Lymphoma: A Single Institute Retrospective Analysis in the Rituximab Era

Keiichi Nakata, MD, Shigeo Fuji, MD PhD, Ryo Nakata, MD, Kazuhito Tsutsumi, MD, Shuhei Kida, MD, Midori Koike, MD, Yuma Tada, MD, Hiroaki Masaie, MD, Hitoshi Yoshida, MD, Jun Ishikawa, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5333.
https://doi.org/10.1182/blood-2018-99-112782
Published: 2018